Imatinib Resistance and Progression of CML to Blast Crisis: Somatic Hypermutation AIDing the Way
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Cell Biology,Oncology
Reference10 articles.
1. Molecular Mechanisms of Antibody Somatic Hypermutation
2. Translation of the Philadelphia chromosome into therapy for CML
3. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
4. Chronic myelogenous leukemia: A review and update of therapeutic strategies
5. The B Cell Mutator AID Promotes B Lymphoid Blast Crisis and Drug Resistance in Chronic Myeloid Leukemia
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Structure-Based Design of First-Generation Small Molecule Inhibitors Targeting the Catalytic Pockets of AID, APOBEC3A, and APOBEC3B;ACS Pharmacology & Translational Science;2021-07-19
2. Nrf-2/Gst-α mediated imatinib resistance through rapid 4-HNE clearance;Experimental Cell Research;2017-04
3. Concomitant AID Expression and BCL7A Loss Associates With Accelerated Phase Progression and Imatinib Resistance in Chronic Myeloid Leukemia;Annals of Laboratory Medicine;2017-03-01
4. H2AX phosphorylation regulated by p38 is involved in Bim expression and apoptosis in chronic myelogenous leukemia cells induced by imatinib;Apoptosis;2014-05-15
5. Serine and proline-rich ligands enriched via phage-display technology show preferential binding to BCR/ABL expressing cells;Hematology/Oncology and Stem Cell Therapy;2014-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3